JP2005531529A5 - - Google Patents

Download PDF

Info

Publication number
JP2005531529A5
JP2005531529A5 JP2003582128A JP2003582128A JP2005531529A5 JP 2005531529 A5 JP2005531529 A5 JP 2005531529A5 JP 2003582128 A JP2003582128 A JP 2003582128A JP 2003582128 A JP2003582128 A JP 2003582128A JP 2005531529 A5 JP2005531529 A5 JP 2005531529A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
pharmaceutical composition
carrier
compound according
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003582128A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005531529A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/007794 external-priority patent/WO2003084929A1/en
Publication of JP2005531529A publication Critical patent/JP2005531529A/ja
Publication of JP2005531529A5 publication Critical patent/JP2005531529A5/ja
Pending legal-status Critical Current

Links

JP2003582128A 2002-04-01 2003-03-24 セリンプロテアーゼ因子xaインヒビターとしての、1−(d−シクロプロピルグリシニル)−4−(ピペリジン−4−イル)ピペラジン化合物 Pending JP2005531529A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36852302P 2002-04-01 2002-04-01
PCT/US2003/007794 WO2003084929A1 (en) 2002-04-01 2003-03-24 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa

Publications (2)

Publication Number Publication Date
JP2005531529A JP2005531529A (ja) 2005-10-20
JP2005531529A5 true JP2005531529A5 (enExample) 2006-05-11

Family

ID=28791889

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003582128A Pending JP2005531529A (ja) 2002-04-01 2003-03-24 セリンプロテアーゼ因子xaインヒビターとしての、1−(d−シクロプロピルグリシニル)−4−(ピペリジン−4−イル)ピペラジン化合物

Country Status (24)

Country Link
US (1) US7166606B2 (enExample)
EP (1) EP1492767B1 (enExample)
JP (1) JP2005531529A (enExample)
KR (1) KR20040094892A (enExample)
CN (1) CN1288135C (enExample)
AT (1) ATE303990T1 (enExample)
AU (1) AU2003218147A1 (enExample)
BR (1) BR0308870A (enExample)
CA (1) CA2478340A1 (enExample)
CR (1) CR7497A (enExample)
DE (1) DE60301569T2 (enExample)
DK (1) DK1492767T3 (enExample)
EA (1) EA007300B1 (enExample)
EC (1) ECSP045329A (enExample)
ES (1) ES2248737T3 (enExample)
HR (1) HRP20040900B1 (enExample)
IL (1) IL164018A0 (enExample)
MX (1) MXPA04009640A (enExample)
NO (1) NO20044688L (enExample)
NZ (1) NZ535402A (enExample)
PL (1) PL373066A1 (enExample)
UA (1) UA76849C2 (enExample)
WO (1) WO2003084929A1 (enExample)
ZA (1) ZA200407418B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6834308B1 (en) 2000-02-17 2004-12-21 Audible Magic Corporation Method and apparatus for identifying media content presented on a media playing device
EP1490767B1 (en) 2001-04-05 2014-06-11 Audible Magic Corporation Copyright detection and protection system and method
US8972481B2 (en) 2001-07-20 2015-03-03 Audible Magic, Inc. Playlist generation method and apparatus
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
EP3541381B1 (en) 2016-11-18 2022-12-28 Merck Sharp & Dohme LLC Inhibitors of factor xiia
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8875798A (en) 1997-08-29 1999-03-22 Proteus Molecular Design Ltd Meta-benzamidine derivatives as serin protease inhibitors
WO2000076970A2 (en) 1999-06-14 2000-12-21 Eli Lilly And Company Serine protease inhibitors
EP1192132B1 (en) 1999-06-14 2005-09-07 Eli Lilly And Company Serine protease inhibitors
GB0030304D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030305D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030306D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030303D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
TWI257389B (en) 2001-06-12 2006-07-01 Lilly Co Eli Pharmaceutical compound
ATE384713T1 (de) * 2001-07-26 2008-02-15 Lilly Co Eli 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazine und -piperidine als faktor-xa-antagonisten

Similar Documents

Publication Publication Date Title
JP2009502743A5 (enExample)
JP2006182786A5 (enExample)
JP2005539088A5 (enExample)
JP2006526031A5 (enExample)
JP2005112864A5 (enExample)
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
MXPA04003007A (es) Compuestos azabiciclico sustituidos condensados con heteroarilo para el tratamiento de enfermedades.
JP2005511698A5 (enExample)
MXPA04004464A (es) Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
JP2005053931A5 (enExample)
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
JP2004137288A5 (enExample)
JP2005523922A5 (enExample)
JP2010521516A5 (enExample)
MXPA04008152A (es) Compuestos azabiciclicos para el tratamiento de enfermedades.
JP2005511697A5 (enExample)
JP2012507535A5 (enExample)
JP2007537301A5 (enExample)
JP2013506674A5 (enExample)
CA2530308A1 (en) 5ht2c receptor agonists for the treatment of diabetes and obesity
JP2004502755A5 (enExample)
JP2012511558A5 (enExample)
JP2005531529A5 (enExample)
JP2004525178A5 (enExample)
JP2009532434A5 (enExample)